MED insider buying and SEC filings, explained
Medifast Inc. · CIK 910329
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Miscellaneous Food Preparations & Kindred Products
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- HEALTHRITE INC
Insider activity in the last 12 months
Bought
$1.7M
Insiders who bought
3
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$226K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28, 2026 | Purchase (code P) | Parsa Kiai (Director) bought 5,557 shares indirectly at $12.24 ($68K), reported as a purchase (code P). Indirect holdings up 37% to 20,428 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 30, 2026, 12:56 PM ET |
| Sep 28–29, 2026 | Planned (10b5-1) | Daniel R Chard (Director) sold 19,089 shares indirectly (by trust) between Sep 28 and Sep 29 at about $11.86 ($226K), marked as a 10b5-1 plan trade. Holdings by trust down 13% to 130,609 shares. | SEC filing Filed Sep 30, 2026 |
| Aug 26, 2026 | Purchase (code P) | Parsa Kiai (Director) bought 43,150 shares indirectly at $12.26 ($529K), reported as a purchase (code P). New position of 20,270 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 28, 2026 |
| Aug 24, 2026 | Purchase (code P) | Parsa Kiai (Director) bought 4,329 shares indirectly at $12.00 ($52K), reported as a purchase (code P). Indirect holdings up 29% to 19,095 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 19–20, 2026 | Purchase (code P) | Parsa Kiai (Director) bought 72,487 shares indirectly between Aug 19 and Aug 20 at about $11.62 ($843K), reported as a purchase (code P). New position of 18,977 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 21, 2026 |
| May 8–11, 2026 | Purchase (code P) | Scott Schlackman (Director) bought 5,000 shares between May 8 and May 11 at about $12.59 ($63K), reported as a purchase (code P). Holdings up 20% to 30,549 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 12, 2026 |
| Mar 20, 2026 | Purchase (code P) | Daniel R Chard (CEO and Director) bought 17,678 shares indirectly at about $10.11 ($179K), reported as a purchase (code P). New position of 17,678 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 27, 2026 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MED in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.